Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone marrow hematopoietic progenitor cells are a diverse group of immature blood-forming cells residing in the bone marrow, responsible for the continuous regeneration of all blood cell types, including lymphoid and myeloid lineages. They include both long-term self-renewing hematopoietic stem cells (HSCs) and lineage-committed multipotent or oligopotent progenitors. These cells are essential for normal hematopoiesis, can be therapeutically harnessed in bone marrow transplantation, and are implicated in malignancies such as leukemia when their differentiation or self-renewal capacity is dysregulated. Their identification relies on specific cell surface antigens (e.g., CD34, c-Kit), and they are studied as targets for both regenerative medicine and chemotherapeutic strategies, but the population itself is not a receptor or discrete molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone marrow hematopoietic progenitor cells (HSPC).